Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor
Clinical trial NCT03023124 · COMPLETED
Trial details
- NCT number
- NCT03023124
- Sponsor
- Italian Sarcoma Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-04
- Primary completion
- 2024-12-06
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.